Quipt Home Medical Corp. reiterates outlook for 2022. Based on the current operations, market trends and completed and prospective acquisitions, the Company is reiterating it outlook for its annual run-rate revenue by the end of calendar 2022 (Fiscal First Quarter 2023) to be $180-$190 million.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
4.57 CAD | +6.53% | +5.54% | -32.30% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.30% | 134M | |
+16.76% | 83.47B | |
-30.53% | 69.72B | |
-3.24% | 26.37B | |
+3.95% | 17.86B | |
-13.25% | 16.83B | |
+1.10% | 15.7B | |
+75.02% | 13.45B | |
+72.98% | 12.81B | |
-1.46% | 12.44B |
- Stock Market
- Equities
- QIPT Stock
- News Quipt Home Medical Corp.
- Quipt Home Medical Corp. Reiterates Outlook for 2022